Group 1: Market Overview - As of December 2, 2025, two stocks in the health care sector are signaling potential warnings for momentum-focused investors [1] - The Relative Strength Index (RSI) is a key momentum indicator, with values above 70 indicating that a stock may be overbought [2] Group 2: Company Highlights - Exact Sciences Corp (NASDAQ:EXAS) is involved in a significant acquisition by Abbott Laboratories for $105 per share, totaling approximately $21 billion in equity value [7] - Exact Sciences' stock has increased by around 51% over the past month, with a 52-week high of $101.87 and an RSI value of 89.8 [7] - Haemonetics Corp (NYSE:HAE) reported strong second-quarter earnings, with earnings per share of $1.27, surpassing the consensus estimate of $1.11 [7] - Haemonetics' quarterly sales reached $327.316 million, exceeding the analyst consensus estimate of $311.399 million, and the stock has gained approximately 61% over the past month [7] - Haemonetics has a 52-week high of $88.31 and an RSI value of 89.4 [7]
Top 2 Health Care Stocks You May Want To Dump This Month